These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15581200)

  • 1. Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
    Lambert ML; Delgado R; Michaux G; Volz A; Van der Stuyft P
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1325-9. PubMed ID: 15581200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaboration between private pharmacies and national tuberculosis programme: an intervention in Bolivia.
    Lambert ML; Delgado R; Michaux G; Vols A; Speybroeck N; Van der Stuyft P
    Trop Med Int Health; 2005 Mar; 10(3):246-50. PubMed ID: 15730509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tuberculosis treatment in private pharmacies, Kathmandu Valley, Nepal.
    Hurtig AK; Pande SB; Baral SC; Porter JD; Bam DS
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):730-6. PubMed ID: 10949324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Private pharmacies and tuberculosis control: a survey of case detection skills and reported anti-tuberculosis drug dispensing in private pharmacies in Ho Chi Minh City, Vietnam.
    Lönnroth K; Lambregts K; Nhien DT; Quy HT; Diwan VK
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1052-9. PubMed ID: 11092718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam.
    Vu DH; van Rein N; Cobelens FG; Nguyen TT; Le VH; Brouwers JR
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1625-9. PubMed ID: 23131260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Referral of tuberculosis symptomatic clients from private pharmacies to public sector clinics for diagnosis and treatment in Cambodia.
    Bell CA; Ilomäki J; Pichenda K; Duncan GJ; Saini B
    J Eval Clin Pract; 2015 Apr; 21(2):285-91. PubMed ID: 25656160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Referring TB suspects from private pharmacies to the National Tuberculosis Programme: experiences from two districts in Ho Chi Minh City, Vietnam.
    Lönnroth K; Karlsson M; Lan NT; Buu TN; Dieu TT
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1147-53. PubMed ID: 14677889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of tuberculosis in an urban setting in Nepal: public-private partnership.
    Newell JN; Pande SB; Baral SC; Bam DS; Malla P
    Bull World Health Organ; 2004 Feb; 82(2):92-8. PubMed ID: 15042230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding private retail drug outlet dispenser knowledge and practices in tuberculosis care in Tanzania.
    Rutta E; Tarimo A; Delmotte E; James I; Mwakisu S; Kasembe D; Konduri N; Silumbe R; Kakanda K; Valimba R
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1108-13. PubMed ID: 25189561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Private pharmacies in tuberculosis control--a neglected link.
    Rajeswari R; Balasubramanian R; Bose MS; Sekar L; Rahman F
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):171-3. PubMed ID: 11931419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider perceptions of pharmacy-initiated tuberculosis referral services in Cambodia, 2005-2010.
    Bell CA; Eang MT; Dareth M; Rothmony E; Duncan GJ; Saini B
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1086-91. PubMed ID: 22687275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimate of the global market for rifampicin-containing fixed-dose combination tablets.
    Norval PY; Blomberg B; Kitler ME; Dye C; Spinaci S
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S292-300; discussion S317-21. PubMed ID: 10593708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
    East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
    Farah MG; Tverdal A; Steen TW; Heldal E; Brantsaeter AB; Bjune G
    BMC Public Health; 2005 Feb; 5():14. PubMed ID: 15698472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment survey of anti-tuberculosis drug management in Cambodia.
    Uchiyama Y; Mao TE; Okada K; Chay S; Kou Soum M; Leng C
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):153-9. PubMed ID: 16499253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New TB drug approved.
    AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.